Actionable news
0
All posts from Actionable news
Actionable news in PFE: PFIZER Inc,

Allergan Is a Good Buy for Investors, With or Without Pfizer

Although the pharmaceuticals industry faced a sharp downturn at the beginning of 2016, that hasn't stopped merger and acquisition (M&A) activity in the sector. In January alone, biotech M&A deals accounted for $56 billion, more than double the value of acquisitions made the year previous.

But there's one merger on the table now that would dwarf all others, Pfizer's (PFE - Get Report) combining with Allergan (a>


More